en · de · es · fr · pt
cardarine-notes.peptides4088.com › Guide › Preclinical Findings And Safety Signals — Common Mistakes

Preclinical Findings And Safety Signals — Common Mistakes

By Editorial Desk · published 2025-07-11 · last reviewed 2025-08-31 · Guide

Reference standard raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2025-08-31. Anything still debated is marked as such rather than presented as settled.

Preclinical Findings and Safety Signals

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Detection, Regulation, and Quality Context

Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.

Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.

Cardarine at a glance

PropertyValueNotes
Primary targetPPARδ (NR1C2)Nuclear receptor involved in lipid metabolism
Preclinical effectIncreased fatty acid oxidationObserved in rodent studies
Key safety signalTumors in rodents after long-term exposureContributed to halted clinical development
Human trial statusNo approved product; development stoppedLimited short-term metabolic data
Sport regulatory statusProhibited at all timesWADA hormone and metabolic modulators class

Identity and Regulatory Status

Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Related pages on this site

Detection, Stability, and Quality

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.

Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.

Reference notes

Electric spark ionization is used to produce gas phase ions from a solid sample. When incorporated with a mass spectrometer the complete instrument is referred to as a spark ionization mass spectrometer or as a spark source mass spectrometer (SSMS). A closed drift ion source uses a radial magnetic field in an annular cavity in order to confine electrons for ionizing a gas. They are used for ion implantation and for space propulsion (Hall-effect thrusters).

The CHMP recommended approval in April 2016, but the FDA rejected the application in November for having insufficient data in November 2016. The drug was authorized in the European Union in May 2016. Germany was the first country where migalastat was launched.

Endocrine glands derive from all three germ layers. The natural decrease in function of the female's ovaries during late middle age results in menopause. The efficiency of all endocrine glands seems to decrease gradually as ageing occurs. This leads to a generalized increase in the incidence of diabetes mellitus and a lower metabolic rate.

A large advertising push by Taco Bell had begun in late February 2011 in response to a consumer protection lawsuit filed against the company by an Alabama law firm. The promotion sought to counter allegations that the company falsely advertised the ratio of ingredients in its beef filling for its tacos. The spots featured employees and franchisees stating that the filling has always been a mixture of 88% beef and various spices and binders and nothing else. The ad followed several full-page print ads in the New York Times and other newspapers that featured the headline "Thank you for suing us." Additionally, the chain added a new social campaign using Twitter and Facebook. The company invested heavily in the campaign, spending more than $3 million (USD) putting out its message—about 20 percent more than the company usually spends on an advertising program. The various campaigns came shortly before the company began its official response to the suit in the United States District Court for the Central District of California and were designed to bring public opinion into their camp. Various analysts stated that the company would have been better off using a grass-root campaign that involved in store advertising and other non-broadcast media. The suit was eventually withdrawn, and the company continued its advertising response by publicly requesting an apology from the suing firm of Beasley Allen. Analyst Laura Ries, of marketing strategy firm Ries & Ries, stated she believed Taco Bell's latest response was a mistake.

The scientific study of the nervous system increased significantly during the second half of the twentieth century, principally due to advances in molecular biology, electrophysiology, and computational neuroscience. This has allowed neuroscientists to study the nervous system in all its aspects: how it is structured, how it works, how it develops, how it malfunctions, and how it can be changed. Compared to psychiatry and psychology, which also study the functioning of the brain, Neuroscience emerged from the earlier fields of Neuro-Immuno-Modulation and Neuroimmunology, which made remarkable breakthroughs beginning with 1945. For example, it became possible to understand, in much detail, the complex processes occurring within a single neuron. Neurons are cells specialized for communication. They are able to communicate with neurons and other cell types through specialized junctions called synapses, at which electrical or electrochemical signals can be transmitted from one cell to another. Many neurons extrude a long thin filament of axoplasm called an axon, which may extend to distant parts of the body and are capable of rapidly carrying electrical signals, influencing the activity of other neurons, muscles, or glands at their termination points. A nervous system emerges from the assemblage of neurons that are connected to each other in neural circuits, and networks. The vertebrate nervous system can be split into two parts: the central nervous system (defined as the brain and spinal cord), and the peripheral nervous system.

Sources: en.wikipedia.org

Notes from published material

An unexpected series of experimental results for the rate of decay of heavy highly charged radioactive ions circulating in a storage ring provoked theoretical activity in an effort to find a convincing explanation. The rates of weak decay of two radioactive species with half-lives of about 40 s and 200 s were reported to have a significant oscillatory modulation, with a period of about 7 s. The reported phenomenon is known as the GSI anomaly, as the storage ring is a facility at the GSI Helmholtz Centre for Heavy Ion Research in Darmstadt, Germany. As the decay process produces an electron neutrino, some of the proposed explanations for the observed rate oscillation invoked neutrino properties. Initial ideas related to flavour oscillation met with skepticism. A 2016 proposal involved mass differences between neutrino mass eigenstates. In a follow-up study published in 2019, measurements of about 9,000 electron-capture decays of hydrogen-like promethium-142 ions showed no periodic modulation. The results were consistent with exponential decay.

== Postpartum function == Postpartum CRF1 knockout mice spend less time nursing and less time licking and grooming their offspring than their wildtype counterparts during the first few days postpartum. These pups weighed less as a result. This pattern of maternal behavior indicates that CRF1 may be needed for early postpartum mothers to display typical mothering behaviors. Maternal aggression is attenuated by increases in CRF and urocortin 2, which bind to CRF1.

Complement 3 (C3) through its interaction with factors B and D (adipsin) generates C3a. In the human body, C3a is rapidly cleaved by carboxypeptidase B or carbxyopeptidase N, that remove the carboxyl-terminal arginine to generate C3adesArg. Thus, most of plasmatic C3a is present in C3adesArg form. C3adesArg is more commonly named ASP or acylation-stimulating-protein due to its marked stimulating action on triacylglycerol synthesis in human adipocytes and skin fibroblasts. ASP is also known for its augmentation of glucose transport and inhibiting action on hormone-sensitive lipase. Because of these actions, it is linked to the pathogenesis of obesity, having been demonstrated to be present at increased levels in patients with obesity, diabetes mellitus type 2 and coronary artery disease. ASP lis a ligand for C5L2, a G-protein-coupled receptor. The view of C3a/C3adesArg as an acylation stimulating activity is not universally accepted. The evidence is discussed in a recent review.

== Further reading == Mortison, JD; Sherman, DH (2010). "Frontiers and opportunities in chemoenzymatic synthesis". J Org Chem. 75 (21): 7041–51. doi:10.1021/jo101124n. PMC 2966535. PMID 20882949. Kim, Jinhyun; Lee, Sahng Ha; Tieves, Florian; Paul, Caroline E.; Hollmann, Frank; Park, Chan Beum (5 July 2019). "Nicotinamide adenine dinucleotide as a photocatalyst". Science Advances. 5 (7): eaax0501. doi:10.1126/sciadv.aax0501.

For services to the Care of the Victims of Torture. Professor Howard Anthony Barnes, Senior Scientist, Unilever Research. For services to Science and Technology. Alison Mary Hore Bastard. For services to the Magistracy in South Devon. Elizabeth Mary Bavidge, Co-Chair, Women's National Commission. For services to Women's Issues. The Very Reverend Trevor Randall Beeson. For services to the Church of England, particularly as Dean of Winchester Cathedral. Hugh Richard Belshaw, lately Finance Director, Oxfam. For Charitable services. Professor Martin Biddle. For services to the Royal Commission on the Historical Monuments of England. Robin Edgar Birley, , Director, Vindolanda Trust. For services to Conservation. Cilla Black. For services to Entertainment. David Blackburn, Senior Management Pay Band 2, the Employment Service, Department for Education and Employment. Peter Kenneth Blair, Managing Director, Racal Research Ltd. For services to the Radar Industry. Victor Harold Blake, Founder Chairman, The London Underwriting Centre (LUC). For services to the Insurance Industry. Charles Conrad Blakey, , Chairman, Kent Probation Committee. For services to the Rehabilitation of Offenders. Ian James Blakey, Director General, British Iron and Steel Producers' Association. For services to Industry. Jennifer Blunt. For services to Medical Research Ethics. Christopher Arthur Booy, Chief Executive, Symonds Group Ltd. For services to the Ministry of Defence. Geoffrey Malcolm Bray, Chairman, Kazakh and Uzbek British Trade and Industry Councils. For services to Export.

Sources: en.wikipedia.org

Background from the literature

The Japanese government reluctantly acceded to the intervention, as British and American diplomatic intercession was not forthcoming, and Japan was in no position to militarily resist three major European powers simultaneously. The three powers had 38 warships with a displacement of 95,000 tons already deployed in East Asia, whereas the Imperial Japanese Navy had only 31 warships in total with a displacement of 57,000 tons. After futile diplomatic efforts to enlist the support of the United States and Great Britain, on 5 May 1895, Prime Minister Itō Hirobumi announced the withdrawal of Japanese forces from the Liaodong Peninsula in exchange for an additional indemnity of 30 million kuping taels (450 million yen). The last Japanese troops departed in December. Much to Japan's astonishment and consternation, Russia moved almost immediately to occupy the entire Liaodong Peninsula and especially to fortify Port Arthur. Germany secured control over concessions in Shandong Province. France and even Great Britain took advantage of a weakened China to seize the port cities of Guangzhouwan and Weihaiwei, respectively, on various pretexts and to expand their spheres of influence. Japan's government felt it had been cheated of its deserved spoils of war by this intervention. This humiliation at the hands of the European powers helped lead to the Gashin Shōtan (臥薪嘗胆) movement.

=== Museums === Abbey House Museum, Leeds Armley Mills Industrial Museum, Leeds Bagshaw Museum, Batley Bankfield Museum, Halifax Bradford Industrial Museum, Eccleshill/Fagley, Bradford Brontë Parsonage Museum, Haworth Colne Valley Museum, Golcar, Huddersfield Eureka, Halifax Leeds City Museum, Leeds National Coal Mining Museum for England Overton, Wakefield National Media Museum, Bradford Pennine Farm Museum, Ripponden, Halifax Pontefract Museum Royal Armouries Museum, Leeds Thackray Museum, Leeds The Hepworth Wakefield Thwaite Mills, Leeds Tolson Museum, Dalton, Huddersfield Wakefield Museum, Wakefield West Yorkshire Folk Museum, Shibden Hall, Halifax Yorkshire Sculpture Park, West Bretton, Wakefield

=== Vision and eye health === Vitamin A status involves eye health via two separate functions. Retinal is an essential factor in rod cells and cone cells in the retina responding to light exposure by sending nerve signals to the brain. An early sign of vitamin A deficiency is night blindness. Vitamin A in the form of retinoic acid is essential to normal epithelial cell functions. Severe vitamin A deficiency, common in infants and young children in southeast Asia causes xerophthalmia characterized by dryness of the conjunctival epithelium and cornea. Untreated, xerophthalmia progresses to corneal ulceration and blindness.

== Cellular and tissue distribution == FPR1 is widely expressed by circulating blood neutrophils, eosinophils, basophils, monocytes, and platelets; tissue-bound macrophages, fibroblasts, and immature dendritic cells; vascular endothelial and smooth muscle cells; various types of epithelial cells, liver hepatocytes, neural tissue glial cells, astrocytes and malignant neuroblastoma cells; skin keratinocytes; and virtually all types of multicellular tissues.

Therefore, the essence of PseAAC is that on one hand it covers the AA composition, but on the other hand it contains the information beyond the AA composition and hence can better reflect the feature of a protein sequence through a discrete model. Meanwhile, various modes to formulate the PseAAC vector have also been developed, as summarized in a 2009 review article.

Sources: en.wikipedia.org

Frequently asked questions

What did animal studies show?

Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.

Has cardarine been tested in humans?

Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.

Does cardarine improve athletic performance in people?

Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.

How is cardarine detected in anti-doping tests?

Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.

Network